Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333 (7 October), doi:10.1136/bmj.333.7571.0-c
Controlled, regulated compensation to living organ donors should be permitted as with donation of other body material, says Amy Friedman (p 746). In the light of severe organ shortages, desperation among people awaiting transplantation, and black markets for kidneys purchased from living donors, she questions why everyone but the donor derives tangible benefit from a living donor transplant. She then discusses how regulation and payment should work in a legalised system to guarantee equitable access.
|
|
Credit: VICTOR DE SCHWANBERG/SPL
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?